686 related articles for article (PubMed ID: 17868423)
1. Total or partial prostate sparing cystectomy for invasive bladder cancer: long-term implications on erectile function.
Davila HH; Weber T; Burday D; Thurman S; Carrion R; Salup R; Lockhart JL
BJU Int; 2007 Nov; 100(5):1026-9. PubMed ID: 17868423
[TBL] [Abstract][Full Text] [Related]
2. [Prostate-sparing cystectomy: long-term functional and oncological results in a series of 25 cases].
Saidi A; Nahon O; Daniel L; Lay F; Lechevallier E; Coulange C
Prog Urol; 2004 Apr; 14(2):172-7; discussion 176. PubMed ID: 15217130
[TBL] [Abstract][Full Text] [Related]
3. Incidental prostate cancer at radical cystoprostatectomy: implications for apex-sparing surgery.
Gakis G; Schilling D; Bedke J; Sievert KD; Stenzl A
BJU Int; 2010 Feb; 105(4):468-71. PubMed ID: 20102366
[TBL] [Abstract][Full Text] [Related]
4. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
[TBL] [Abstract][Full Text] [Related]
5. [Radical cystectomy with sparing partial prostate for invasive bladder cancer].
Zhou FJ; Qin ZK; Han H; Liu ZW; Wu ZG
Ai Zheng; 2003 Oct; 22(10):1066-9. PubMed ID: 14558952
[TBL] [Abstract][Full Text] [Related]
6. Prostatic capsule and seminal vesicle-sparing cystectomy: improved functional results, inferior oncologic outcome.
Simone G; Papalia R; Leonardo C; Sacco R; Damiano R; Guaglianone S; Forastiere E; Gallucci M
Urology; 2008 Jul; 72(1):162-6. PubMed ID: 18372008
[TBL] [Abstract][Full Text] [Related]
7. Seminal sparing cystectomy and ileocapsuloplasty: long-term followup results.
Muto G; Bardari F; D'Urso L; Giona C
J Urol; 2004 Jul; 172(1):76-80. PubMed ID: 15201741
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes after sexuality preserving cystectomy and neobladder (prostate sparing cystectomy) in 44 patients.
Nieuwenhuijzen JA; Meinhardt W; Horenblas S
J Urol; 2005 Apr; 173(4):1314-7. PubMed ID: 15758788
[TBL] [Abstract][Full Text] [Related]
9. Prostatic capsule- and seminal-sparing cystectomy for bladder carcinoma: initial results for selected patients.
Botto H; Sebe P; Molinie V; Herve JM; Yonneau L; Lebret T
BJU Int; 2004 Nov; 94(7):1021-5. PubMed ID: 15541120
[TBL] [Abstract][Full Text] [Related]
10. Management of superficial bladder carcinoma: time to rethink the treatment strategies in the era of orthotopic neo-bladder.
Singh PB; Kumar A; Das SK; Pandey AK; Sharma GK; Samir Swain HB; Trivedi S; Dwivedi US
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):881-5. PubMed ID: 20814125
[TBL] [Abstract][Full Text] [Related]
11. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
[TBL] [Abstract][Full Text] [Related]
12. Overall clinical outcomes after nerve and seminal sparing radical cystectomy for the treatment of organ confined bladder cancer.
Colombo R; Bertini R; Salonia A; Naspro R; Ghezzi M; Mazzoccoli B; Deho' F; Montorsi F; Rigatti P
J Urol; 2004 May; 171(5):1819-22; discussion 1822. PubMed ID: 15076284
[TBL] [Abstract][Full Text] [Related]
13. Surgically treated transitional cell carcinomas of the bladder. The role of radical surgery.
Al-Ali MA; Kashmoula DM; Haddad LF
Saudi Med J; 2002 Jun; 23(6):695-9. PubMed ID: 12070550
[TBL] [Abstract][Full Text] [Related]
14. Potency preserving cystectomy with intrafascial prostatectomy for high risk superficial bladder cancer.
Puppo P; Introini C; Bertolotto F; Naselli A
J Urol; 2008 May; 179(5):1727-32; discussion 1732. PubMed ID: 18343421
[TBL] [Abstract][Full Text] [Related]
15. Oncological evaluation of prostate sparing cystectomy: the Montsouris long-term results.
Rozet F; Lesur G; Cathelineau X; Barret E; Smyth G; Soon S; Vallancien G
J Urol; 2008 Jun; 179(6):2170-4; discussion 2174-5. PubMed ID: 18423740
[TBL] [Abstract][Full Text] [Related]
16. Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
Solsona E; Climent MA; Iborra I; Collado A; Rubio J; Ricós JV; Casanova J; Calatrava A; Monrós JL
Eur Urol; 2009 Apr; 55(4):911-9. PubMed ID: 18722046
[TBL] [Abstract][Full Text] [Related]
17. Prostate-sparing cystectomy: two sides of the moon.
Muto G
Eur Urol; 2008 Feb; 53(2):237-9. PubMed ID: 17706861
[No Abstract] [Full Text] [Related]
18. Cavernous nerve graft reconstruction during radical prostatectomy or radical cystectomy: safe and technically feasible.
Anastasiadis AG; Benson MC; Rosenwasser MP; Salomon L; El-Rashidy H; Ghafar MA; McKiernan JM; Burchardt M; Shabsigh R
Prostate Cancer Prostatic Dis; 2003; 6(1):56-60. PubMed ID: 12664067
[TBL] [Abstract][Full Text] [Related]
19. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
[TBL] [Abstract][Full Text] [Related]
20. Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?
Denzinger S; Fritsche HM; Otto W; Blana A; Wieland WF; Burger M
Eur Urol; 2008 Jan; 53(1):146-52. PubMed ID: 17624657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
